Named to Institutional Investor’s 2022 All-Japan Executive Team, Christophe Weber shares lessons learned from 2021 and future opportunities for innovation.
Christophe Weber speaks with Masahiko Uotani, President and CEO of Japanese cosmetic giant Shiseido, at the 23rd Nikkei Global Management Forum. As Takeda celebrates its 240th anniversary, Shiseido is celebrating its 150th, and both global companies with Japanese roots are embracing change through innovation as they look to the future. The conversation covers how a company grows strong with innovation
Takeda's finance teams continue to work with the business to drive post-acquisition cost savings and competitive margins, while supporting investment in R&D and new product launches. Learn more here
Takeda’s Phase III SOLSTICE trial of maribavir in transplant recipients with CMV infection was named Clinical Advance of the Year at the 2021 Scrip Awards. Learn more here
Recently, during Fast Company’s Innovation Festival, Takeda sponsored a virtual panel with President and CEO Christophe Weber speaking alongside Delta Air Lines’ CEO Ed Bastian and BSR’s President and CEO Aron Cramer. Among the topics discussed were the threat posed by climate change and what it takes to curb it. Learn more here.
As Takeda makes Fortune’s Global 500 for the second consecutive year, Takeda’s President and CEO Christophe Weber speaks with Fortune’s Alan Murray about our global transformation, innovative R&D pipeline and focus on purpose-led sustainability. Watch here.
Named to Institutional Investor’s 2021 All-Japan Executive Team as a top-scoring chief executive, Christophe Weber shares insight into Takeda’s innovation strategy.
Christophe Weber, named by Insider as one of 10 leaders transforming healthcare in Asia, reflects on Takeda’s transformation to a global, R&D-driven biopharmaceutical company.
In life, there are great opportunities as well as great challenges and risks. With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
In the final installment of this interview series, Christophe Weber talks about the challenges of globalization with his message for the Japanese business community.
Christophe Weber on Takeda’s corporate governance system and the importance of being open and transparent to build trust.
Christophe Weber talks about how confidentiality was maintained during Shire negotiations and the challenges of large-scale integration.
President and CEO Christophe Weber explains how Takeda is developing “Global Talent” with the ability to perform on an international business stage.
Takeda was named Pharma Company of the Year at the 2019 Scrip Awards. The award winner is chosen by Scrip’s senior editorial team to honor outstanding achievements and strategic advancements over the past year.
Despite technological advances, the delivery of high-quality health care remains a human-centered activity. Takeda is supporting NGO Seed Global Health to use the power of people to tackle the health challenges of sub-Saharan Africa.
Takeda says Shire buyout good for image (Jan 16, 2019 - NHK World)
Takeda rings NYSE opening bell after listing (Jan 16, 2019 - The Mainichi)
Takeda CEO Vows 'Responsible Pricing' After Mega Pharmaceutical Merger (Jan 16, 2019 - Cheddar)
This pharmaceutical company is like four biotechs in one, says CEO (Jan 15, 2019 - CNBC)
Takeda Pharmaceutical CEO Talks Big Pharma Trends (TheStreet: Jan 15th, 2019)
The Australian at the centre of Takeda's deal for Shire (PharmaDispatch: Jan 10th, 2019)
Takeda Is Focused on Innovation Through R&D, CEO Says (Bloomberg TV: Jan 9th, 2019)
Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future (Forbes: Jan 7th, 2019)
CEO Christophe Weber speaks openly to Eurobiz Japan on the ups and downs of Takeda's `total transformation`, his strategic approach to R&D and of the exciting promise of what's to come.